EU External Trade - Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure

Extra-EU sourcing of Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure is highly concentrated. 🇨🇭 Switzerland captures 75.7% of imports (€1.9B), followed by 🇮🇳 India (9.0%). With an HHI of 5891, this Concentrated market exposes the EU to supply dependency risks.

European exports of Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure are concentrated on a few markets. 🇨🇦 Canada accounts for 51.8% (€3.2B), ahead of 🇺🇸 United States (28.5%). The top three destinations are 🇨🇦 Canada, 🇺🇸 United States, 🇨🇭 Switzerland.

Within the EU, 🇮🇪 Ireland concentrates 67.8% of Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure imports, well ahead of 🇸🇮 Slovenia (9.5%). The top importing member states are 🇮🇪 Ireland, 🇸🇮 Slovenia, 🇩🇪 Germany.

The year 2025 marked a turning point: both imports and exports were falling sharply, shifting by -62.0% and -53.8% respectively.